There are two clues in evaluating which issue is causing the elevation in MMP-9 (although as with many of these things, this is not a black and white matter)
10.3390/ijms21155178 163 WrightD
Flags theoretical pathologic angiogenesis potential: PMC12446177 Evidence summary Preclinical: IBD/colitis models: High remission rates, restored mucosal architecture, improved barrier function Tendon repair: Accelerated healing, improved tensile strength, reduced fibrosis Neurovascular: Sciatic nerve protection, enhanced blood vessel growth in nerve tissue Human data (emerging): Interstitial cystitis pilot (2024, n=12): 10/12 complete resolution, 2/12 at 80% improvement IV safety study (2025, n=2): no adverse effects on cardiac, hepatic, renal, or glucose biomarkers Knee series (Lee): 17 patients identified, 16 analysed
Ipamorelin has a terminal plasma half-life of about 2 hours in human pharmacokinetic data (Gobburu et al
Will I need regular lab testing while on therapy
However, these consumer-facing platforms suffer from chronic stockouts and rarely provide the batch-specific third-party COAs required by rigorous researchers